{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:35:26Z","timestamp":1791588926807,"version":"4.3.4"},"reference-count":145,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2020-02181"],"award-info":[{"award-number":["2020-02181"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement in Gothenburg","award":["237551"],"award-info":[{"award-number":["237551"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Oncostatin M (OSM), which belongs to the IL-6 family of cytokines, is the most potent and effective stimulator of osteoclast formation in this family, as assessed by different in vitro assays. Osteoclastogenesis induced by the IL-6 type of cytokines is mediated by the induction and paracrine stimulation of the osteoclastogenic cytokine receptor activator of nuclear factor \u03ba-B ligand (RANKL), expressed on osteoblast cell membranes and targeting the receptor activator of nuclear factor \u03ba-B (RANK) on osteoclast progenitor cells. The potent effect of OSM on osteoclastogenesis is due to an unusually robust induction of RANKL in osteoblasts through the OSM receptor (OSMR), mediated by a JAK\u2013STAT\/MAPK signaling pathway and by unique recruitment of the adapter protein Shc1 to the OSMR. Gene deletion of Osmr in mice results in decreased numbers of osteoclasts and enhanced trabecular bone caused by increased trabecular thickness, indicating that OSM may play a role in physiological regulation of bone remodeling. However, increased amounts of OSM, either through administration of recombinant protein or of adenoviral vectors expressing Osm, results in enhanced bone mass due to increased bone formation without any clear sign of increased osteoclast numbers, a finding which can be reconciled by cell culture experiments demonstrating that OSM can induce osteoblast differentiation and stimulate mineralization of bone nodules in such cultures. Thus, in vitro studies and gene deletion experiments show that OSM is a stimulator of osteoclast formation, whereas administration of OSM to mice shows that OSM is not a strong stimulator of osteoclastogenesis in vivo when administered to adult animals. These observations could be explained by our recent finding showing that OSM is a potent stimulator of the osteoclastogenesis inhibitor WNT16, acting in a negative feedback loop to reduce OSM-induced osteoclast formation.<\/jats:p>","DOI":"10.3390\/ijms23063287","type":"journal-article","created":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T21:30:14Z","timestamp":1647811814000},"page":"3287","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Stimulation of Osteoclast Formation by Oncostatin M and the Role of WNT16 as a Negative Feedback Regulator"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7266-6061","authenticated-orcid":false,"given":"Pedro P. C.","family":"de Souza","sequence":"first","affiliation":[{"name":"The Innovation in Biomaterials Laboratory, School of Dentistry, Federal University of Goi\u00e1s, Goi\u00e2nia 74690-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Henning","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Osteoporosis Centre and Centre for Bone and Arthritis Research at the Sahlgrenska Academy, University of Gothenburg, 413 45 Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf H.","family":"Lerner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Osteoporosis Centre and Centre for Bone and Arthritis Research at the Sahlgrenska Academy, University of Gothenburg, 413 45 Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.cellbio.042308.113308","article-title":"Genetic Control of Bone Formation","volume":"25","author":"Karsenty","year":"2009","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bone.2015.02.016","article-title":"Quantifying the osteocyte network in the human skeleton","volume":"75","author":"Buenzli","year":"2015","journal-title":"Bone"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/er.2012-1026","article-title":"The Osteocyte: An Endocrine Cell \u2026 and More","volume":"34","author":"Dallas","year":"2013","journal-title":"Endocr. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nm.2452","article-title":"Evidence for osteocyte regulation of bone homeostasis through RANKL expression","volume":"17","author":"Nakashima","year":"2011","journal-title":"Nat. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm.2448","article-title":"Matrix-embedded cells control osteoclast formation","volume":"17","author":"Xiong","year":"2011","journal-title":"Nat. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.tem.2012.05.005","article-title":"New insights into osteoclastogenic signaling mechanisms","volume":"23","author":"Nakashima","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3109\/08820139.2013.822766","article-title":"The role of cytokines in inflammatory bone loss","volume":"42","author":"Souza","year":"2013","journal-title":"Immunol. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cell.2021.02.002","article-title":"Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption","volume":"184","author":"McDonald","year":"2021","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.semcdb.2020.05.016","article-title":"Osteoclast formation at the bone marrow\/bone surface interface: Importance of structural elements, matrix, and intercellular communication","volume":"112","author":"Delaisse","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev-physiol-021119-034425","article-title":"Osteoclasts Provide Coupling Signals to Osteoblast Lineage Cells Through Multiple Mechanisms","volume":"82","author":"Sims","year":"2020","journal-title":"Annu. Rev. Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"a031211","DOI":"10.1101\/cshperspect.a031211","article-title":"Regulation of Bone Metabolism by Sex Steroids","volume":"8","author":"Khosla","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_12","unstructured":"Zaidi, M. (2020). Role of Interleukins on Physiological and Pathological Bone Resorption and Bone Formation: Effects by Cytokines in The IL-6 and IL-10 Families. Encyclopedia of Bone Biology, Academic Press."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"155655","DOI":"10.1016\/j.cyto.2021.155655","article-title":"Influences of the IL-6 cytokine family on bone structure and function","volume":"146","author":"Sims","year":"2021","journal-title":"Cytokine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.2147\/JIR.S323435","article-title":"WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M","volume":"14","author":"Henning","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/345442a0","article-title":"The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene","volume":"345","author":"Yoshida","year":"1990","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1073\/pnas.87.12.4828","article-title":"Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op\/op) mouse","volume":"87","author":"Bartocci","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood.V99.1.111","article-title":"Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects","volume":"99","author":"Dai","year":"2002","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.1154370","article-title":"Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular Proteome","volume":"320","author":"Lin","year":"2008","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Chen, Z., Buki, K., V\u00e4\u00e4r\u00e4niemi, J., Gu, G., and V\u00e4\u00e4n\u00e4nen, H.K. (2011). The Critical Role of IL-34 in Osteoclastogenesis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018689"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11154-014-9308-6","article-title":"RANKL\/OPG: Critical role in bone physiology","volume":"16","author":"Martin","year":"2015","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"108124","DOI":"10.1016\/j.celrep.2020.108124","article-title":"OPG Production Matters Where It Happened","volume":"32","author":"Tsukasaki","year":"2020","journal-title":"Cell Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"108052","DOI":"10.1016\/j.celrep.2020.108052","article-title":"Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption","volume":"32","author":"Cawley","year":"2020","journal-title":"Cell Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","article-title":"Osteoimmunology: Evolving concepts in bone\u2013immune interactions in health and disease","volume":"19","author":"Tsukasaki","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"25190","DOI":"10.1074\/jbc.272.40.25190","article-title":"TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells","volume":"272","author":"Wong","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1152\/physrev.00036.2016","article-title":"Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems","volume":"97","author":"Okamoto","year":"2017","journal-title":"Physiol. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1073\/pnas.0912779107","article-title":"Blimp1-mediated repression of negative regulators is required for osteoclast differentiation","volume":"107","author":"Nishikawa","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/annrheumdis-2014-207137","article-title":"RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation","volume":"75","author":"Danks","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e143060","DOI":"10.1172\/JCI143060","article-title":"Plasma cells promote osteoclastogenesis and periarticular bone loss in autoimmune arthritis","volume":"131","author":"Komatsu","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-03147-6","article-title":"Host defense against oral microbiota by bone-damaging T cells","volume":"9","author":"Tsukasaki","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.83.24.9739","article-title":"Oncostatin M: A growth regulator produced by differentiated histiocytic lymphoma cells","volume":"83","author":"Zarling","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1365-2141.1997.8522478.x","article-title":"Serum oncostatin M in multiple myeloma: Association with prognostic factors","volume":"96","author":"Koskela","year":"1997","journal-title":"Br. J. Haematol."},{"key":"ref_37","first-page":"2042","article-title":"Oncostatin-M as a novel biomarker in colon cancer patients and its association with clinicopathologic variables","volume":"18","author":"Gurluler","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/MPA.0000000000000155","article-title":"Serum Cytokine Profile in Patients with Pancreatic Cancer","volume":"43","author":"Torres","year":"2014","journal-title":"Pancreas"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nm.4307","article-title":"Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor\u2013neutralizing therapy in patients with inflammatory bowel disease","volume":"23","author":"West","year":"2017","journal-title":"Nat. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/art.20166","article-title":"Secretion of oncostatin M by neutrophils in rheumatoid arthritis","volume":"50","author":"Cross","year":"2004","journal-title":"Arthritis Care Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/13547500903573209","article-title":"Serum levels of oncostatin M (a gp 130 cytokine): An inflammatory biomarker in periodontal disease","volume":"15","author":"Pradeep","year":"2009","journal-title":"Biomarkers"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/labinvest.3780220","article-title":"Oncostatin M Production by Blood and Alveolar Neutrophils during Acute Lung Injury","volume":"81","author":"Grenier","year":"2001","journal-title":"Lab. Investig."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/cyto.2002.1023","article-title":"Oncostatin M Production by Human Dendritic Cells in Response to Bacterial Products","volume":"17","author":"Suda","year":"2002","journal-title":"Cytokine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.4049\/jimmunol.139.9.2977","article-title":"Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells","volume":"139","author":"Brown","year":"1987","journal-title":"J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ajpath.2014.11.008","article-title":"Oncostatin M, an Inflammatory Cytokine Produced by Macrophages, Supports Intramembranous Bone Healing in a Mouse Model of Tibia Injury","volume":"185","author":"Guihard","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1172\/JCI40568","article-title":"Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice","volume":"120","author":"Walker","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"15760","DOI":"10.1074\/jbc.272.25.15760","article-title":"Signaling of Type II Oncostatin M Receptor","volume":"272","author":"Auguste","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3340297","article-title":"Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway","volume":"334","author":"Heinrich","year":"1998","journal-title":"Biochem. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/geno.1993.1294","article-title":"The Genes for Oncostatin M (OSM) and Leukemia Inhibitory Factor (LIF) Are Tightly Linked on Human Chromosome 22","volume":"17","author":"Rose","year":"1993","journal-title":"Genomics"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0969-2126(00)00176-3","article-title":"Crystal structure and functional dissection of the cytostatic cytokine oncostatin M","volume":"8","author":"Deller","year":"2000","journal-title":"Structure"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.1542794","article-title":"The IL-6 signal transducer, gp130: An oncostatin M receptor and affinity converter for the LIF receptor","volume":"255","author":"Gearing","year":"1992","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"32635","DOI":"10.1074\/jbc.271.51.32635","article-title":"Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation","volume":"271","author":"Mosley","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"10991","DOI":"10.1016\/S0021-9258(19)78081-8","article-title":"Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors","volume":"269","author":"Sporeno","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"10891","DOI":"10.1158\/0008-5472.CAN-06-1766","article-title":"Oncostatin M (OSM) cytostasis of breast tumor cells: Characterization of an OSM receptor beta-specific kernel","volume":"66","author":"Heath","year":"2006","journal-title":"Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1172\/JCI118432","article-title":"Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal\/osteoblastic cells","volume":"97","author":"Bellido","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1210\/endo-127-4-1602","article-title":"Leukemia Inhibitory Factor Binds with High Affinity to Preosteoblastic RCT-1 Cells and Potentiates the Retinoic Acid Induction of Alkaline Phosphatase","volume":"127","author":"Rodan","year":"1990","journal-title":"Endocrinology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.4049\/jimmunol.169.6.3353","article-title":"IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae","volume":"169","author":"Palmqvist","year":"2002","journal-title":"J. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jcp.1041450116","article-title":"Osteoblasts display receptors for and responses to leukemia-inhibitory factor","volume":"145","author":"Allan","year":"1990","journal-title":"J. Cell. Physiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3389\/fimmu.2019.01164","article-title":"Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor","volume":"10","author":"Persson","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cyto.2014.04.001","article-title":"Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts","volume":"68","author":"Singbrant","year":"2014","journal-title":"Cytokine"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"129907","DOI":"10.1016\/j.bbagen.2021.129907","article-title":"Cross-reactivity of two human IL-6 family cytokines OSM and LIF explored by protein-protein docking and molecular dynamics simulation","volume":"1865","author":"Du","year":"2021","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"12737","DOI":"10.1073\/pnas.0705577104","article-title":"An unusual cytokine: Ig-domain interaction revealed in the crystal structure of leukemia inhibitory factor (LIF) in complex with the LIF receptor","volume":"104","author":"Huyton","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1074\/jbc.RA118.001920","article-title":"The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation","volume":"293","author":"Schindler","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"20181","DOI":"10.1074\/jbc.RA118.004375","article-title":"The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice","volume":"293","author":"Sreenivasan","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"8641","DOI":"10.1073\/pnas.88.19.8641","article-title":"Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6","volume":"88","author":"Rose","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/0092-8674(94)90449-9","article-title":"The crystal structure and biological function of leukemia inhibitory factor: Implications for receptor binding","volume":"77","author":"Robinson","year":"1994","journal-title":"Cell"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1073\/pnas.90.24.11924","article-title":"Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6","volume":"90","author":"Tamura","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"19301","DOI":"10.1074\/jbc.274.27.19301","article-title":"STAT3 activation in stromal\/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroid hormone","volume":"274","author":"Gubrij","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1006\/cyto.1999.0635","article-title":"Stimulation of Osteoclast Differentiation In Vitro by Mouse Oncostatin M, Leukaemia Inhibitory Factor, Cardiotrophin-1 and Interleukin 6: Synergy with Dexamethasone","volume":"12","author":"Richards","year":"2000","journal-title":"Cytokine"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.tem.2009.12.004","article-title":"Prostaglandins in bone: Bad cop, good cop?","volume":"21","author":"Blackwell","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"21703","DOI":"10.1074\/jbc.M116.748483","article-title":"Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass","volume":"291","author":"Walker","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/bcp.13766","article-title":"Osteoanabolic and dual action drugs","volume":"85","author":"Tabacco","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/jbmr.1506","article-title":"Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo","volume":"27","author":"Walker","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1210\/endo.137.4.8625883","article-title":"Oncostatin-M: A new bone active cytokine that activates osteoblasts and inhibits bone resorption","volume":"137","author":"Jay","year":"1996","journal-title":"Endocrinology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI19872","article-title":"Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways","volume":"113","author":"Sims","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.bone.2006.02.074","article-title":"A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation","volume":"39","author":"Itoh","year":"2006","journal-title":"Bone"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1128\/MCB.18.6.3357","article-title":"Cloning and Characterization of a Specific Receptor for Mouse Oncostatin M","volume":"18","author":"Lindberg","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cytogfr.2015.07.006","article-title":"Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology","volume":"26","author":"Hermanns","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.4049\/jimmunol.163.12.6651","article-title":"Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130","volume":"163","author":"Hermanns","year":"1999","journal-title":"J. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.8272872","article-title":"Association of Transcription Factor APRF and Protein Kinase Jak1 with the Interleukin-6 Signal Transducer gp130","volume":"263","author":"Wegenka","year":"1994","journal-title":"Science"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"11349","DOI":"10.1073\/pnas.88.24.11349","article-title":"Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family","volume":"88","author":"Murakami","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1006\/bbrc.1994.1970","article-title":"Tyrosine phosphorylation of JAK-TYK kinases in malignant plasma cell lines growth-stimulated by interleukins 6 and 11","volume":"202","author":"Berger","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1006\/bbrc.1994.1525","article-title":"Interleukin-6-Induced Tyrosine Phosphorylation of Multiple Proteins in Murine Hematopoietic Lineage Cells","volume":"200","author":"Matsuda","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.8272873","article-title":"Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components","volume":"263","author":"Stahl","year":"1994","journal-title":"Science"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"19465","DOI":"10.1074\/jbc.M710157200","article-title":"Box 2 Region of the Oncostatin M Receptor Determines Specificity for Recruitment of Janus Kinases and STAT5 Activation","volume":"283","author":"Hintzen","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/j.1460-2075.1995.tb07128.x","article-title":"A major role for the protein tyrosine kinase JAK1 in the JAK\/STAT signal transduction pathway in response to interleukin-6","volume":"14","author":"Guschin","year":"1995","journal-title":"EMBO J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.cellsig.2005.03.010","article-title":"Multiple reasons for an inefficient STAT1 response upon IL-6-type cytokine stimulation","volume":"17","author":"Haan","year":"2005","journal-title":"Cell. Signal."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0092-8674(00)81166-6","article-title":"Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses","volume":"93","author":"Rodig","year":"1998","journal-title":"Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1210\/me.2008-0058","article-title":"Leukemia Inhibitory Factor Regulates Trophoblast Giant Cell Differentiation via Janus Kinase 1-Signal Transducer and Activator of Transcription 3-Suppressor of Cytokine Signaling 3 Pathway","volume":"22","author":"Takahashi","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"12991","DOI":"10.1074\/jbc.271.22.12991","article-title":"Differential activation of acute phase response factor\/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation","volume":"271","author":"Gerhartz","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"848","DOI":"10.4049\/jimmunol.164.2.848","article-title":"The cytoplasmic tyrosine motifs in full-length glycoprotein 130 have different roles in IL-6 signal transduction","volume":"164","author":"Schmitz","year":"2000","journal-title":"J. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7871432","article-title":"Contribution of STAT SH2 Groups to Specific Interferon Signaling by the Jak-STAT pathway","volume":"267","author":"Heim","year":"1995","journal-title":"Science"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"12999","DOI":"10.1074\/jbc.271.22.12999","article-title":"Differential activation of acute phase response factor\/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. II. Src homology SH2 domains define the specificity of stat factor activation","volume":"271","author":"Hemmann","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1074-7613(00)80501-4","article-title":"Two Signals Are Necessary for Cell Proliferation Induced by a Cytokine Receptor gp130: Involvement of STAT3 in Anti-Apoptosis","volume":"5","author":"Fukada","year":"1996","journal-title":"Immunity"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.cellsig.2012.12.008","article-title":"p42\/p44-MAPK and PI3K are sufficient for IL-6 family cytokines\/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK\/STAT activation","volume":"25","author":"Fahmi","year":"2013","journal-title":"Cell. Signal."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"9703","DOI":"10.1074\/jbc.273.16.9703","article-title":"Activation of Phosphatidylinositol 3-Kinase through Glycoprotein 130 Induces Protein Kinase B and p70 S6 Kinase Phosphorylation in Cardiac Myocytes","volume":"273","author":"Oh","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"40742","DOI":"10.1074\/jbc.M005408200","article-title":"Non-redundant signal transduction of interleukin-6-type cytokines. The adapter protein Shc is specifically recruited to rhe oncostatin M receptor","volume":"275","author":"Hermanns","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1210\/me.2006-0315","article-title":"Transcriptional control of receptor activator of nuclear factor-kappaB ligand by the protein kinase A activator forskolin and the transmembrane glycoprotein 130-activating cytokine, oncostatin M, is exerted through multiple distal enhancers","volume":"21","author":"Kim","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"25273","DOI":"10.1074\/jbc.M002296200","article-title":"Receptor Subunit-specific Action of Oncostatin M in Hepatic Cells and Its Modulation by Leukemia Inhibitory Factor","volume":"275","author":"Wang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5334\/1750-2187-12-2","article-title":"Insights into the Shc Family of Adaptor Proteins","volume":"12","author":"Ahmed","year":"2017","journal-title":"J. Mol. Signal."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1038\/sj.onc.1204776","article-title":"Signaling via Shc family adapter proteins","volume":"20","author":"Ravichandran","year":"2001","journal-title":"Oncogene"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0092-8674(92)90536-L","article-title":"A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction","volume":"70","author":"Pelicci","year":"1992","journal-title":"Cell"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"22370","DOI":"10.1074\/jbc.M200280200","article-title":"The p66Shc Longevity Gene Is Silenced through Epigenetic Modifications of an Alternative Promoter","volume":"277","author":"Ventura","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0002-9440(10)64330-1","article-title":"Adenoviral Gene Transfer of Interleukin-1 in Combination with Oncostatin M Induces Significant Joint Damage in a Murine Model","volume":"162","author":"Rowan","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/ar1460","article-title":"A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK\/RANKL","volume":"7","author":"Hui","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1128\/MCB.15.5.2349","article-title":"Developmental abnormalities in mice transgenic for bovine oncostatin M","volume":"15","author":"Malik","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0002-9440(10)61120-0","article-title":"Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand","volume":"160","author":"Bennink","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Nicolaidou, V., Wong, M.M., Redpath, A.N., Ersek, A., Baban, D.F., Williams, L.M., Cope, A.P., and Horwood, N.J. (2012). Monocytes Induce STAT3 Activation in Human Mesenchymal Stem Cells to Promote Osteoblast Formation. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039871"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.2249","article-title":"Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture","volume":"44","author":"Estrada","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Zheng, H.-F., Tobias, J.H., Duncan, E., Evans, D.M., Eriksson, J., Paternoster, L., Yerges-Armstrong, L.M., Lehtim\u00e4ki, T., Bergstr\u00f6m, U., and K\u00e4h\u00f6nen, M. (2012). WNT16 Influences Bone Mineral Density, Cortical Bone Thickness, Bone Strength, and Osteoporotic Fracture Risk. PLoS Genet., 8.","DOI":"10.1371\/journal.pgen.1002745"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm.3654","article-title":"Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures","volume":"20","author":"Henning","year":"2014","journal-title":"Nat. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1210\/en.2014-1702","article-title":"Role of WNT16 in the Regulation of Periosteal Bone Formation in Female Mice","volume":"156","author":"Wergedal","year":"2015","journal-title":"Endocrinology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1210\/en.2015-1281","article-title":"Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice","volume":"157","author":"Alam","year":"2016","journal-title":"Endocrinology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/JOE-18-0020","article-title":"Inducible Wnt16 inactivation: WNT16 regulates cortical bone thickness in adult mice","volume":"237","author":"Ohlsson","year":"2018","journal-title":"J. Endocrinol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/0006-291X(89)90851-6","article-title":"Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis","volume":"162","author":"Bloys","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","article-title":"IL-6 is produced by osteoblasts and induces bone resorption","volume":"145","author":"Ishimi","year":"1990","journal-title":"J. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.biocel.2016.08.003","article-title":"Cell-specific paracrine actions of IL-6 family cytokines from bone, marrow and muscle that control bone formation and resorption","volume":"79","author":"Sims","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1126\/science.1083901","article-title":"Hexameric structure and assembly of the interleukin-6\/IL-6 alpha-receptor\/gp130 complex","volume":"300","author":"Boulanger","year":"2003","journal-title":"Science"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"26943","DOI":"10.1074\/jbc.M115.682138","article-title":"Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex","volume":"290","author":"Lacroix","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_121","first-page":"1682","article-title":"Bone marrow neutrophilia and suppressed bone turnover in human interleukin-6 transgenic mice. A cellular relationship among hematopoietic cells, osteoblasts, and osteoclasts mediated by stromal cells in bone marrow","volume":"147","author":"Kitamura","year":"1995","journal-title":"Am. J. Pathol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/art.22175","article-title":"Impaired skeletal development in interleukin-6\u2013transgenic mice: A model for the impact of chronic inflammation on the growing skeletal system","volume":"54","author":"Rucci","year":"2006","journal-title":"Arthritis Care Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/j.1460-2075.1994.tb06368.x","article-title":"Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion","volume":"13","author":"Poli","year":"1994","journal-title":"EMBO J."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1621100","article-title":"Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6","volume":"257","author":"Jilka","year":"1992","journal-title":"Science"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bone.2018.04.015","article-title":"IL-6 trans -signalling mediates trabecular, but not cortical, bone loss after ovariectomy","volume":"112","author":"Lazzaro","year":"2018","journal-title":"Bone"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1172\/JCI117130","article-title":"Interleukin-11: A new cytokine critical for osteoclast development","volume":"93","author":"Girasole","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S8756-3282(02)00784-6","article-title":"Characterization of the bone-resorptive effect of interleukin-11 in cultured mouse calvarial bones","volume":"31","author":"Ahlen","year":"2002","journal-title":"Bone"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/endo.139.11.6433","article-title":"Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells","volume":"139","author":"Horwood","year":"1998","journal-title":"Endocrinology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1359\/JBMR.050209","article-title":"Interleukin-11 Receptor Signaling Is Required for Normal Bone Remodeling","volume":"20","author":"Sims","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"49011","DOI":"10.1074\/jbc.M207804200","article-title":"Interleukin-11 as a Stimulatory Factor for Bone Formation Prevents Bone Loss with Advancing Age in Mice","volume":"277","author":"Takeuchi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/cyto.2002.1981","article-title":"Neutralization of interleukin-11 activity decreases osteoclast formation and increases cancellous bone volume in ovariectomized mice","volume":"20","author":"Shaughnessy","year":"2002","journal-title":"Cytokine"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1359\/jbmr.080706","article-title":"Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling","volume":"23","author":"Walker","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00223-010-9337-4","article-title":"Ciliary Neurotrophic Factor Inhibits Bone Formation and Plays a Sex-Specific Role in Bone Growth and Remodeling","volume":"86","author":"McGregor","year":"2010","journal-title":"Calcif. Tissue Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1074\/jbc.M116.764779","article-title":"Interleukin 27 (IL-27) Alleviates Bone Loss in Estrogen-deficient Conditions by Induction of Early Growth Response-2 Gene","volume":"292","author":"Shukla","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00774-007-0766-8","article-title":"Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: Inhibitory effects on osteoclast differentiation","volume":"25","author":"Kamiya","year":"2007","journal-title":"J. Bone Miner. Metab."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.4049\/jimmunol.0802091","article-title":"IL-27 abrogates receptor activator of NF-kappa B ligand-mediated osteoclastogenesis of human granulocyte-macrophage colony-forming unit cells through STAT1-dependent inhibition of c-Fos","volume":"183","author":"Furukawa","year":"2009","journal-title":"J. Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.27200","article-title":"Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling","volume":"62","author":"Kalliolias","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2567.2012.03622.x","article-title":"Interleukin-27 suppresses osteoclastogenesis via induction of interferon-gamma","volume":"137","author":"Park","year":"2012","journal-title":"Immunology"},{"key":"ref_139","first-page":"1154","article-title":"Interleukin-27 prevents LPS-induced inflammatory osteolysis by inhibiting osteoclast formation and function","volume":"11","author":"Li","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5114\/ceji.2018.77384","article-title":"IL-35 inhibits human osteoclastogenesis from monocytes induced by receptor-activator of NF-kappaB ligand","volume":"43","author":"Yago","year":"2018","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3389\/fimmu.2018.01417","article-title":"Interleukin-35 Inhibits TNF-alpha-Induced Osteoclastogenesis and Promotes Apoptosis via Shifting the Activation from TNF Receptor-Associated Death Domain (TRADD)-TRAF2 to TRADD-Fas-Associated Death Domain by JAK1\/STAT1","volume":"9","author":"Peng","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-2249.2000.01114.x","article-title":"Osteoblasts and stromal cells isolated from femora in rheumatoid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leukaemia inhibitory factor and oncostatin M","volume":"119","author":"Lisignoli","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1172\/jci.insight.96034","article-title":"Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications","volume":"2","author":"Torossian","year":"2017","journal-title":"JCI Insight"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1947601912458284","article-title":"Oncostatin M Promotes Mammary Tumor Metastasis to Bone and Osteolytic Bone Degradation","volume":"3","author":"Bolin","year":"2012","journal-title":"Genes Cancer"},{"key":"ref_145","first-page":"185","article-title":"gp130 Cytokines Activate Novel Signaling Pathways and Alter Bone Dissemination in ER+ Breast Cancer Cells","volume":"7","author":"Omokehinde","year":"2022","journal-title":"J. Bone Miner. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/6\/3287\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:39:01Z","timestamp":1760135941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/6\/3287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":145,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["ijms23063287"],"URL":"https:\/\/doi.org\/10.3390\/ijms23063287","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]}}}